Removal of persistent pharmaceutical micropollutants from sewage by addition of PAC in a sequential membrane bioreactor

Water Research

Volumn 45, Issue 16, 2011, Pages 5323-5333

  Serrano, D ^a   Suarez S ^a   Lema, J M ^a   Omil, F ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Activated carbon; Pharmaceutical organic micropollutants; Sequencing batch membrane bioreactor (SMBR); Sorption

Indexed keywords

ACTIVATED CARBON; ANTIBIOTICS; BIOCONVERSION; BIOREACTORS; CHEMICAL OXYGEN DEMAND; NITROGEN REMOVAL; ORGANIC CARBON; SEWAGE;

CARBAMAZEPINE; CARBON ADDITION; MICROPOLLUTANTS; ORGANIC MICROPOLLUTANTS; PHARMACEUTICAL ORGANIC MICROPOLLUTANT; POWDERED ACTIVATED CARBON; ROXITHROMYCIN; SEQUENCING BATCH MEMBRANE BIOREACTOR; TRIMETHOPRIM;

AMIDES;

ACTIVATED CARBON; AMMONIA; AMMONIUM NITROGEN; CARBAMAZEPINE; DIAZEPAM; DICLOFENAC; ERYTHROMYCIN; FLUOXETINE; IBUPROFEN; NAPROXEN; NITROGEN; PHOSPHORUS; POWDERED ACTIVATED CARBON; ROXITHROMYCIN; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ABUNDANCE; ACTIVATED CARBON; AERATION; AMMONIUM; BACTERIUM; BIOMASS; BIOREACTOR; CHEMICAL POLLUTANT; COMMUNITY COMPOSITION; DRUG; MEMBRANE; MICROBIAL ACTIVITY; MICROBIAL ECOLOGY; ORGANIC POLLUTANT; POLLUTANT REMOVAL; SEWAGE; SORPTION; URBAN AREA; WASTEWATER;

ACCUMULIBACTER PHOSPHATIS; AERATION; ARTICLE; BIOMASS; CHEMICAL OXYGEN DEMAND; MEMBRANE REACTOR; NITROSOMONAS; NUTRIENT; PHARMACEUTICAL MICROPOLLUTANT; PKA; POLLUTANT; PRIORITY JOURNAL; SEQUENTIAL MEMBRANE BATCH REACTOR; SEWAGE; WASTE COMPONENT REMOVAL; WASTE WATER;

ACCUMULIBACTER PHOSPHATIS; NITROSOMONAS;

EID: 80052271574     PISSN: 00431354     EISSN: 18792448     Source Type: Journal    
DOI: 10.1016/j.watres.2011.07.037     Document Type: Article

References (51)

1. Aktas O., Cecen F. Addition of activated carbon to batch activated sludge reactors in the treatment of landfill leachate and domestic wastewater. Journal of Chemical Technology and Biotechnology 2001, 76(8):793-802.
2. Amann R., Ludwig W., Schleifer K.H. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiological Reviews 1995, 59(1):143-169.
3. Amann R., Ludwig W., Schulze R., Spring S., Moore E., Schleifer K.H. rRNA-targeted oligonucleotide probes for the identification of genuine and former pseudomonads. Systematic and Applied Microbiology 1996, 19(4):501-509.
4. Andersen H., Siegrist H., Halling-Sorensen B., Ternes T.A. Fate of estrogens in a municipal sewage treatment plant. Environmental Science & Technology 2003, 37:4021-4026.
5. Andreottola G., Folodori F., Ragazzi M. On-line control for a SBR system for nitrogen removal from industrial wastewater. Water Science and Technology 2001, 43(3):93-100.
6. APHA Standard Methods for the Examination of Water and Wastewater 1999, American Public Health Association/American Water Works Association/Water Environment Federation, Washington DC, USA. twentieth ed.
7. Arias C.A., Bubba M.D., Brix H. Phosphorus removal by sands for use as media in surface flow constructed reed beds. Water Research 2001, 35(5):1159-1168.
8. Babić S., Horvat A.J.M., Pavlović D.M., Kaštelan-Macan M. Determination of pKa values of active pharmaceutical ingredients. Trends in Analytical Chemistry 2007, 26(11):1043-1061.
9. Batt A.L., Kim S., Aga D.S. Enhanced biodegradation of iopromide and trimethoprim in nitrifying activated sludge. Environmental Science & Technology 2006, 40(23):7367-7373.
10. Brooks B.W., Foran C.M., Richards S.M., Weston J., Turner P.K., Stanley J.K., Solomon K.R., Slattery M., La Point T.W. Aquatic ecotoxicology of fluoxetine. Toxicology Letters 2003, 142(3):169-183.
11. Castiglioni S., Zuccato E., Crisci E., Chiabrando C., Fanelli R., Bagnati R. Identification and measurement of illicit drugs and their metabolites in urban wastewater by liquid chromatography-tandem mass spectrometry. Analytical Chemistry 2006, 78(24):8421-8429.
12. Crocetti G.R., Hugenholtz P., Bond P.L., Schuler A., Keller J., Jenkins D., Blackall L.L. Identification of polyphosphate-accumulating organisms and design of 16S rRNA-directed probes for their detection and quantification. Applied and Environmental Microbiology 2000, 66(3):1175-1182.
13. Daims H., Nielsen J.L., Nielsen P.H., Schleifer K.H., Wagner M. In situ characterization of nitrospira-like nitrite-oxidizing bacteria active in wastewater treatment plants. Applied and Environmental Microbiology 2001, 67(11):5273-5284.
14. Fukuhara T., Iwasaki S., Kawashima M., Shinohara O., Abe I. Adsorbability of estrone and 17β-estradiol in water onto activated carbon. Water Research 2006, 40(2):241-248.
15. Göbel A., McArdell C.S., Joss A., Siegrist H., Giger W. Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. Science of the Total Environment 2007, 372(2-3):361-371.
16. Jenkins D., Richard G.M., Daigger T.G. Manual on the Causes and Control of Activated Sludge Bulking and Foaming and Other Solids Separation Problems 2004, Lewis Publishers, Washington, DC.
17. Jones O.A.H., Voulvoulis N., Lester J.N. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Research 2002, 36(20):5013-5022.
18. Joss A., Keller E., Alder A.C., Göbel A., McArdell C.S., Ternes T., Siegrist H. Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Research 2005, 39(14):3139-3152.
19. Kämpfer P., Wagner M. Filamentous bacteria in activated sludge: current taxonomic status and ecology. The Encyclopedia of Environmental Microbiology 2002, Wiley, New York. G. Bitton (Ed.).
20. Kim J.S., Lee C.H., Chun H.D. Comparison of ultrafiltration characteristics between activated sludge and BAC sludge. Water Research 1998, 32(11):3443-3451.
21. Kimura K., Hara H., Watanabe Y. Elimination of selected acidic pharmaceuticals from municipal wastewater by an activated sludge system and membrane bioreactors. Environmental Science & Technology 2007, 41(10):3708-3714.
22. Kwon J.W., Armbrust K.L. Laboratory persistence and fate of fluoxetine in aquatic environments. Environmental Toxicology & Chemistry 2006, 25(10):2561-2568.
23. Li X., Hai F.I., Nghiem L.D. Simultaneous activated carbon adsorption within a membrane bioreactor for an enhanced micropollutant removal. Bioresource Technology 2011, 102(9):5319-5324.
24. Li Y.Z., He Y.L., Liu Y.H., Yang S.C., Zhang G.J. Comparison of the filtration characteristics between biological powdered activated carbon sludge and activated sludge in submerged membrane bioreactors. Desalination 2005, 174(3):305-314.
25. Lindqvist N., Tuhkanen T., Kronberg L. Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Research 2005, 39(11):2219-2228.
26. Manz W., Amann R., Ludwig W., Wagner M., Schleifer K.H. Phylogenetic oligodeoxynucleotide probes for the major subclasses of Proteobacteria: problems and solutions. Systematic and Applied Microbiology 1992, 15(4):593-600.
27. Mobarry B.K., Wagner M., Urbain V., Rittmann B.E., Stahl D.A. Phylogenetic probes for analyzing abundance and spatial organization of nitrifying bacteria. Applied and Environmental Microbiology 1996, 62(6):2156-2162.
28. Ng A.S., Stenstrom M.K. Nitrification in powdered activated carbon activated sludge process. Journal of Environmental Engineering 1987, 113(6):1285-1301.
29. Park W.H., Polprasert C. Roles of oyster shells in an integrated constructed wetland system designed for P removal. Ecological Engineering 2008, 34(1):50-56.
30. Prochaska C.A., Zouboulis A.I. Removal of phosphates by pilot vertical-flow constructed wetlands using a mixture of sand and dolomite as substrate. Ecological Engineering 2006, 26(3):293-303.
31. Reif R., Suárez S., Omil F., Lema J.M. Fate of pharmaceuticals and cosmetic ingredients during the operation of a MBR treating sewage. Desalination 2008, 221(1-3):511-517.
32. Remy M., Van der Marela P., Zwijnenburg A., Rulkens W., Temmink H. Low dose powdered activated carbon addition at high sludge retention times to reduce fouling in membrane bioreactors. Water Research 2009, 43(2):345-350.
33. Rodríguez I., Quintana J.B., Carpinteiro J., Carro A.M., Lorenz R.A., Cela R. Determination of acidic drugs in sewage water by gas cromatography-mass spectrometry as tert -butyldimethylsilyl derivatives. Journal of Chromatography A 2003, 985(1-2):265-274.
34. Satyawali Y., Balakrishman M. Effect of PAC addition on sludge properties in an MBR treating high strength wastewater. Water Research 2009, 43(6):1577-1588.
35. Serrano D., Lema J.M., Omil F. Influence of the employment of adsorption and coprecipitation agents for the removal of PPCPs in conventional activated sludge (CAS) system. Water Science and Technology 2010, 62(3):728-735.
36. Sirianuntapiboon S., Ungkaprasatcha O. Removal of Pb+2 and Ni+2 by bio-sludge in sequencing batch reactor (SBR) and granular activated carbon-SBR (GAC-SBR) system. Bioresource Technology 2007, 98(14):2749-2757.
37. Snyder S.A., Adham S., Redding A.M., Cannon F.S., DeCarolis J., Oppenheimer J. Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination 2007, 202(1-2):156-181.
38. Suarez S., Lema J.M., Omil F. Removal of pharmaceutical and personal care products (PPCPs) under nitrifying and denitrigying conditions. Water Research 2010, 44(10):3214-3224.
39. Suárez S., Carballa M., Omil F., Lema J.M. How are pharmaceutical and personal care products (PPCPs) removed from urban wasterwaters?. Reviews in Environmental Science Biotechnology 2008, 7(2):125-138.
40. Ternes T.A., Herrmann N., Bonerz M., Knacker T., Siegrist H., Joss A. Determination of Kd-values for pharmaceuticals and musk fragrances in sewage sludge. Water Research 2004, 38(19):4075-4084.
41. Ternes T.A., Joss A. Human Pharmaceuticals, Hormones and Fragrances: The Challenge of Micropollutants in Urban Water Management 2006, IWA, London.
42. Thuy Q.T.T., Visvanathan C. Removal of inhibitory phenolic compounds by biological activated carbon coupled membrane bioreactor. Water Science and Technology 2006, 53(11):89-97.
43. Urase T., Kikuta T. Separate estimation of adsorption and degradation of pharmaceutical substances and estrogens in the activated sludge process. Water Research 2005, 39(7):1289-1300.
44. Vanderford B.J., Pearson R.A., Rexing D.J., Snyder S.A. Analysis of endocrine disruptors, pharmaceuticals, and personal care products in water using liquid chromatography/tandem mass spectrometry. Analytical Chemistry 2003, 75(22):6265-6274.
45. Wang Z., Wang P., Wang Q., Wu Z., Zhou Q., Yang D. Effective control of membrane fouling by filamentous bacteria in a submerged membrane bioreactor. Chemical Engineering Journal 2010, 158(3):608-615.
46. Wagner M., Rath G., Amann R. In situ identification of ammonia-oxidizing bacteria. Systematic and Applied Microbiology 1995, 18(2):251-264.
47. Wagner M., Rath G., Koops H.P., Flood J., Amann R. In situ analysis of nitrifying bacteria in sewage treatment plants. Water Science and Technology 1996, 34(1-2):237-244.
48. Westerhoff P., Yoon Y., Snyder S., Wert E. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environmental Science & Technology 2005, 39(17):6649-6663.
49. Widjaja T., Miyata T., Nakano Y., Nishijima W., Okada M. Adsorption capacity of powdered activated carbon for 3,5-dichlorophenol in activated sludge. Chemosphere 2004, 57(9):1219-1224.
50. Ying G., Kookana R.S., Kolpin D.W. Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies. Journal of Environmental Monitoring 2009, 11(8):1498-1505.
51. Zorita S., Martensson L., Mathiasson L. Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden. Science of the Total Environment 2009, 407(8):2760-2770.